Therapeutic Potential of Targeting Stromal Crosstalk-Mediated Immune Suppression in Pancreatic Cancer
The stroma-rich, immunosuppressive microenvironment is a hallmark of pancreatic ductal adenocarcinoma (PDA). Tumor cells and other cellular components of the tumor microenvironment, such as cancer associated fibroblasts, CD4+ T cells and myeloid cells, are linked by a web of interactions. Their cros...
Main Authors: | Wenting Du, Marina Pasca di Magliano, Yaqing Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-07-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2021.682217/full |
Similar Items
-
Pancreatic Fibroblast Heterogeneity: From Development to Cancer
by: Paloma E. Garcia, et al.
Published: (2020-11-01) -
Epithelial-Myeloid cell crosstalk regulates acinar cell plasticity and pancreatic remodeling in mice
by: Yaqing Zhang, et al.
Published: (2017-10-01) -
Change isn't always better
by: Heather Schofield, et al.
Published: (2015-08-01) -
Kras as a key oncogene and therapeutic target in pancreatic cancer.
by: Meredith A Collins, et al.
Published: (2014-01-01) -
Dynamic Stromal Alterations Influence Tumor-Stroma Crosstalk to Promote Pancreatic Cancer and Treatment Resistance
by: Kendelle J. Murphy, et al.
Published: (2021-07-01)